168 related articles for article (PubMed ID: 31802946)
1. Serum Apolipoprotein A-I Combined With C-Reactive Protein Serves As A Novel Prognostic Stratification System For Colorectal Cancer.
Ye J; Luo QY; Wang XP; Liu ZY; Chen MX; Huang H; Zhang L
Cancer Manag Res; 2019; 11():9265-9276. PubMed ID: 31802946
[TBL] [Abstract][Full Text] [Related]
2. High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma.
Wang XP; Li XH; Zhang L; Lin JH; Huang H; Kang T; Mao MJ; Chen H; Zheng X
BMC Cancer; 2016 Jul; 16():516. PubMed ID: 27444612
[TBL] [Abstract][Full Text] [Related]
3. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.
Mao M; Wang X; Sheng H; Liu Y; Zhang L; Dai S; Chi PD
BMC Cancer; 2018 Nov; 18(1):1178. PubMed ID: 30486825
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective study.
Xie H; Wei L; Wang Q; Tang S; Gan J
Front Endocrinol (Lausanne); 2024; 15():1318416. PubMed ID: 38919478
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.
Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Li Z; Xue Y; Zhang M; Liu R; Zhou F; Han H
Medicine (Baltimore); 2016 Mar; 95(12):e3147. PubMed ID: 27015197
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
Chi PD; Liu W; Chen H; Zhang JP; Lin Y; Zheng X; Liu W; Dai S
PLoS One; 2014; 9(3):e91080. PubMed ID: 24625581
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and therapeutic value of serum lipids and a new IPI score system based on apolipoprotein A-I in diffuse large B-cell lymphoma.
Yu T; Luo D; Luo C; Xu-Monette ZY; Yu L
Am J Cancer Res; 2023; 13(2):475-484. PubMed ID: 36895983
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.
Zhou J; Wei W; Hou H; Ning S; Li J; Huang B; Liu K; Zhang L
Front Cell Dev Biol; 2021; 9():637650. PubMed ID: 34765598
[No Abstract] [Full Text] [Related]
9. Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT).
Zhang L; Ye J; Luo Q; Kuang M; Mao M; Dai S; Wang X
Cancer Manag Res; 2020; 12():5373-5384. PubMed ID: 32753955
[TBL] [Abstract][Full Text] [Related]
10. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of high triglyceride and apolipoprotein B levels in patients with stage III and high-risk stage II colorectal cancer undergoing curative surgery.
Chen XQ; Wu PW; Liu DH; Yan SJ; Shen XM; Yang LY
Oncol Lett; 2020 Jul; 20(1):705-714. PubMed ID: 32565996
[TBL] [Abstract][Full Text] [Related]
12. Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer.
Lin Q; Liu W; Xu S; Sun L
Arch Gynecol Obstet; 2022 Mar; 305(3):683-691. PubMed ID: 34453586
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L
Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347
[TBL] [Abstract][Full Text] [Related]
14. Lipid metabolism changes in patients with severe COVID-19.
Li Y; Zhang Y; Lu R; Dai M; Shen M; Zhang J; Cui Y; Liu B; Lin F; Chen L; Han D; Fan Y; Zeng Y; Li W; Li S; Chen X; Li H; Pan P
Clin Chim Acta; 2021 Jun; 517():66-73. PubMed ID: 33639119
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases.
Wang Y; Wang ZQ; Wang FH; Lei XF; Yan SM; Wang DS; Zhang F; Xu RH; Wang LY; Li YH
Oncotarget; 2016 Aug; 7(35):57290-57300. PubMed ID: 27344180
[TBL] [Abstract][Full Text] [Related]
16. Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancer.
Shi H; Huang H; Pu J; Shi D; Ning Y; Dong Y; Han Y; Zarogoulidis P; Bai C
Onco Targets Ther; 2018; 11():6995-7003. PubMed ID: 30410356
[TBL] [Abstract][Full Text] [Related]
17. Novel parameter based on lipid indicators ratio improves prognostic value of plasma lipid levels in resectable colorectal cancer patients.
Gu JN; Yao S; Cao YH; Deng SH; Mao FW; Jiang HY; He YT; Li XY; Ke SQ; Li HL; Li H; Liu XH; Liu HL; Wang JL; Wu K; Liu L; Cai KL
World J Gastrointest Surg; 2021 Jul; 13(7):689-701. PubMed ID: 34354802
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Zhang Y; Yang X
Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nomogram integrated baseline serum lipids for patients with non-esophageal squamous cell carcinoma.
Chen S; Li X; Wen X; Peng S; Xue N; Xing S; Liu Y
Ann Transl Med; 2019 Oct; 7(20):548. PubMed ID: 31807530
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis.
Liu MM; Chen ZH; Zhao LY; Zhao JY; Rong DL; Ma XK; Ruan DY; Lin JX; Qi JJ; Hu PS; Wen JY; Chen J; Lin Q; Wu XY; Wei L; Dong M
Oncol Res Treat; 2021; 44(9):450-468. PubMed ID: 34380137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
